GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2026 4:53:58 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $948,340 -7.5% | Assets $44,709,903 | EPS -$0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/15/2026 4:24:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $983,536 -13.4% | Assets $45,143,790 | EPS -$0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 4/1/2026 4:23:21 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $4,144,268 -8.5% | Assets $30,999,464 | EPS -$0.74 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2025 4:30:12 PM | View | Proxy | SEC | Y 2024 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/12/2025 4:22:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $756,217 -31.3% | Assets $15,804,793 | EPS -$0.17 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2025 4:25:49 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,025,767 +10.9% | Assets $13,766,560 | EPS -$0.16 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2025 4:33:39 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,136,287 -17.0% | Assets $14,217,073 | EPS -$0.24 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/31/2025 4:32:43 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $4,528,929 -35.4% | Assets $14,887,524 | EPS -$0.27 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/13/2024 4:21:49 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $1,100,152 -39.0% | Assets $13,465,610 | EPS -$0.06 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/12/2024 4:12:21 PM | View | Proxy | SEC | Y 2023 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2024 4:20:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $924,943 -15.8% | Assets $14,261,233 | EPS -$0.09 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/15/2024 4:27:55 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $1,369,839 -30.1% | Assets $16,190,449 | EPS -$0.07 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 4/1/2024 4:20:54 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $7,011,299 -13.5% | Assets $16,469,200 | EPS -$0.91 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/13/2023 4:17:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $1,803,461 -8.3% | Assets $15,352,357 | EPS -$0.06 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/7/2023 4:08:28 PM | View | Proxy | SEC | Y 2022 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2023 3:55:20 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $1,097,862 -31.9% | Assets $15,704,309 | EPS -$0.35 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/12/2023 4:22:58 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $1,960,290 +22.2% | Assets $17,356,240 | EPS -$0.29 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/30/2023 5:07:37 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $8,104,092 -15.9% | Assets $17,784,143 | EPS -$3.78 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2022 4:59:52 PM | View | Proxy | SEC | Y 2021 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2022 4:26:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,965,931 -0.6% | Assets $16,203,518 | EPS -$0.16 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/11/2022 4:19:45 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $1,613,156 -33.2% | Assets $17,918,449 | EPS -$0.18 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/12/2022 4:28:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $1,604,005 -32.0% | Assets $21,043,210 | EPS -$0.22 | |
| China Pharma Holdings, Inc. (CPHI) | 3/31/2022 8:06:51 AM | View | Financials | Earnings | WIRE | 1Q 2022 | Rev $1,604,005 -32.0% | Assets $21,043,210 | EPS -$0.22 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/30/2022 4:16:31 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $9,641,925 -11.3% | Assets $22,649,767 | EPS -$0.74 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/15/2021 5:34:40 PM | View | Proxy | SEC | Y 2020 | ||||||
| China Pharma Holdings, Inc. (CPHI) | 11/12/2021 4:32:12 PM | View | Financials | Earnings | WIRE | 3Q 2021 | Rev $1,978,627 -17.6% | Assets $18,183,295 | EPS -$0.02 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/12/2021 4:16:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $1,978,627 -17.6% | Assets $18,183,295 | EPS -$0.02 | |
| China Pharma Holdings, Inc. (CPHI) | 8/13/2021 4:35:07 PM | View | Financials | Earnings | WIRE | 2Q 2021 | Rev $2,415,559 -35.9% | Assets $19,944,241 | EPS -$0.02 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/13/2021 4:12:02 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $2,415,559 -35.9% | Assets $19,944,241 | EPS -$0.02 | |
| China Pharma Holdings, Inc. (CPHI) | 5/14/2021 4:38:57 PM | View | Financials | Earnings | WIRE | 1Q 2021 | Rev $2,358,371 +33.7% | Assets $19,847,593 | Export Earnings Model | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2021 4:24:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $2,358,371 +33.7% | Assets $19,847,593 | ||
| China Pharma Holdings, Inc. (CPHI) | 3/26/2021 5:04:01 PM | View | Financials | Earnings | WIRE | Y 2020 | Rev $2,931,104 -3.8% | Assets $21,117,991 | EPS -$0.03 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/26/2021 4:14:38 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $10,866,449 -0.5% | Assets $21,117,991 | EPS -$0.07 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/16/2020 4:09:38 PM | View | Proxy | SEC | Y 2019 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/13/2020 4:16:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $2,400,667 +1.0% | Assets $21,124,890 | EPS -$0.02 | |
| China Pharma Holdings, Inc. (CPHI) | 11/13/2020 4:11:41 PM | View | Financials | Earnings | WIRE | 3Q 2020 | Rev $2,400,667 +1.0% | Assets $21,124,890 | EPS -$0.02 | Export Earnings Model | |
| China Pharma Holdings, Inc. (CPHI) | 8/14/2020 6:34:53 AM | View | Financials | Earnings | WIRE | 2Q 2020 | Rev $3,770,723 +46.8% | Assets $23,165,021 | Export Earnings Model | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/13/2020 4:23:09 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Rev: $3,770,723 +46.8% | Assets $23,165,021 | ||
| China Pharma Holdings, Inc. (CPHI) | 5/15/2020 6:34:37 AM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $1,763,955 -39.8% | Assets $22,435,664 | EPS -$0.02 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2020 4:15:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Rev: $1,763,955 -39.8% | Assets $22,435,664 | EPS -$0.02 | |
| China Pharma Holdings, Inc. (CPHI) | 4/14/2020 4:40:45 PM | View | Financials | Earnings | WIRE | 1Q 2020 | Rev $1,763,955 -39.8% | Assets $22,435,664 | EPS -$0.02 | Export Earnings Model | |
| China Pharma Holdings, Inc. (CPHI) | 3/31/2020 6:41:16 AM | View | Financials | Earnings | WIRE | Y 2019 | Rev $3,048,411 -6.0% | Assets $22,235,222 | EPS -$0.44 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/30/2020 5:00:18 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Rev: $10,923,936 -11.4% | Assets $22,235,222 | EPS -$0.48 | |
| China Pharma Holdings, Inc. (CPHI) | 11/15/2019 8:12:55 AM | View | Financials | Earnings | WIRE | 3Q 2019 | Rev $2,376,844 +3.4% | Assets $39,900,631 | EPS -$0.02 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2019 4:25:31 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Rev: $2,376,844 +3.4% | Assets $39,900,631 | EPS -$0.02 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/6/2019 5:28:07 PM | View | Proxy | SEC | Y 2018 | ||||||
| China Pharma Holdings, Inc. (CPHI) | 8/15/2019 6:37:59 AM | View | Financials | Earnings | WIRE | 2Q 2019 | Rev $2,569,408 -19.0% | Assets $43,030,370 | EPS -$0.02 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2019 4:23:22 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Rev: $2,569,408 -19.0% | Assets $43,030,370 | EPS -$0.02 | |
| China Pharma Holdings, Inc. (CPHI) | 5/15/2019 6:06:34 AM | View | Financials | Earnings | WIRE | 1Q 2019 | Rev $2,929,273 -19.0% | Assets $45,241,123 | EPS -$0.01 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2019 4:45:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Rev: $2,929,273 -19.0% | Assets $45,241,123 | EPS -$0.01 | |
| China Pharma Holdings, Inc. (CPHI) | 3/29/2019 6:14:36 AM | View | Financials | Earnings | WIRE | Y 2018 | Rev $3,242,820 -15.7% | Assets $45,377,325 | EPS -$0.18 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/28/2019 4:18:21 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $12,330,687 -6.7% | Assets $45,377,325 | EPS -$0.25 | |
| China Pharma Holdings, Inc. (CPHI) | 11/15/2018 6:11:16 AM | View | Financials | Earnings | WIRE | 3Q 2018 | Rev $2,298,472 -27.3% | Assets $52,534,740 | EPS -$0.04 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2018 4:42:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Rev: $2,298,472 -27.3% | Assets $52,534,740 | EPS -$0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 10/25/2018 2:24:46 PM | View | Proxy | SEC | Y 2017 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2018 4:39:57 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Rev: $3,173,711 +8.8% | Assets $58,308,079 | EPS -$0.02 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2018 4:19:04 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $3,615,684 +10.1% | Assets $62,126,972 | EPS -$0.01 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 4/2/2018 5:09:17 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $13,212,314 -15.1% | Assets $59,952,900 | EPS -$0.44 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2017 4:15:06 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $3,162,222 +1.2% | Assets $74,994,506 | EPS -$0.05 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/3/2017 5:01:23 PM | View | Proxy | SEC | Y 2016 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2017 4:25:00 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $2,917,180 -25.0% | Assets $77,124,593 | EPS -$0.05 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/11/2017 5:15:33 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Rev: $3,285,203 -9.8% | Assets $78,142,976 | EPS -$0.02 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/31/2017 4:21:20 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 12/31/2016 | Rev: $15,570,514 -23.5% | Assets $78,520,140 | EPS -$0.21 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/31/2017 6:00:42 AM | View | Financials | Earnings | SEC | Y 2016 | Rev $5,262,194 +16.8% | Assets $78,520,140 | EPS -$0.08 | Export Earnings Model | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2016 4:07:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 9/30/2016 | Rev: $3,125,596 -30.2% | Assets $87,408,224 | EPS -$0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 10/28/2016 3:52:44 PM | View | Proxy | SEC | Y 2015 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/11/2016 4:25:18 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 6/30/2016 | Rev: $3,890,902 -31.4% | Assets $91,977,253 | EPS -$0.06 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/16/2016 4:41:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 3/31/2016 | Rev: $3,640,494 -36.1% | Assets $97,032,134 | EPS -$0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/30/2016 4:11:40 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 12/31/2015 | Rev: $20,351,630 -8.1% | Assets $96,513,825 | EPS -$0.35 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 12/28/2015 7:48:54 AM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $4,479,113 -19.5% | Assets $108,923,540 | EPS $0.07 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 12/28/2015 7:46:44 AM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $5,674,175 -7.4% | Assets $115,412,373 | EPS $0.03 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 12/28/2015 7:43:04 AM | Micro | View | Financials | 10-Q/A | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $5,694,930 -19.9% | Assets $118,035,125 | EPS -$0.09 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 12/28/2015 7:39:07 AM | Micro | View | Financials | 10-K/A | SEC | Y 2014 ending: 12/31/2014 | Rev: $22,133,866 -32.5% | Assets $121,084,486 | EPS -$0.91 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/16/2015 4:10:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 9/30/2015 | Rev: $4,479,113 -19.5% | Assets $108,923,540 | EPS $0.07 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 10/28/2015 5:36:01 PM | View | Proxy | SEC | Y 2014 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2015 9:26:01 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 6/30/2015 | Rev: $5,674,175 -7.4% | Assets $115,412,373 | EPS $0.03 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/11/2015 4:05:47 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 3/31/2015 | Rev: $5,694,930 -19.9% | Assets $118,035,125 | EPS -$0.09 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/30/2015 4:01:17 PM | Micro | View | Financials | 10-K | SEC | Y 2014 ending: 12/31/2014 | Rev: $22,133,866 -32.5% | Assets $121,084,486 | EPS -$0.91 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/20/2014 5:30:22 PM | View | Proxy | SEC | Y 2013 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2014 4:05:54 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 9/30/2014 | Rev: $5,566,543 -31.4% | Assets $140,532,528 | EPS -$0.15 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2014 4:05:36 PM | Small | View | Financials | 10-Q | SEC | 2Q 2014 ending: 6/30/2014 | Rev: $6,130,544 -23.6% | Assets $146,029,648 | EPS -$0.20 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/15/2014 9:30:14 AM | Small | View | Financials | 10-Q | SEC | 1Q 2014 ending: 3/31/2014 | Rev: $7,105,515 -13.9% | Assets $154,344,931 | EPS -$0.05 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/20/2014 4:05:54 PM | Small | View | Financials | 10-K | SEC | Y 2013 ending: 12/31/2013 | Rev: $32,806,678 -39.8% | Assets $157,610,954 | EPS -$0.46 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2013 4:26:32 PM | Small | View | Financials | 10-Q | SEC | 3Q 2013 ending: 9/30/2013 | Rev: $8,116,599 -33.3% | Assets $162,487,228 | EPS -$0.05 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/6/2013 4:29:07 PM | View | Proxy | SEC | Y 2012 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2013 5:55:09 PM | Small | View | Financials | 10-Q | SEC | 2Q 2013 ending: 6/30/2013 | Rev: $8,026,325 -45.0% | Assets $158,933,242 | EPS -$0.10 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2013 4:35:38 PM | Small | View | Financials | 10-Q | SEC | 1Q 2013 ending: 3/31/2013 | Rev: $8,249,387 -48.7% | Assets $159,259,612 | EPS -$0.06 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/14/2013 4:32:59 PM | Small | View | Financials | 10-K | SEC | Y 2012 ending: 12/31/2012 | Rev: $54,507,049 -32.8% | Assets $163,239,913 | EPS $0.11 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/19/2012 4:00:19 PM | View | Proxy | SEC | Y 2011 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2012 4:07:03 PM | Small | View | Financials | 10-Q | SEC | 3Q 2012 ending: 9/30/2012 | Rev: $12,176,344 -42.0% | Assets $166,046,823 | EPS $0.03 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 8/14/2012 4:06:32 PM | Small | View | Financials | 10-Q | SEC | 2Q 2012 ending: 6/30/2012 | Rev: $14,598,403 -25.5% | Assets $164,886,022 | EPS $0.04 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/14/2012 5:12:01 PM | Small | View | Financials | 10-Q | SEC | 1Q 2012 ending: 3/31/2012 | Rev: $16,086,731 -11.2% | Assets $163,624,173 | EPS $0.06 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/14/2012 5:13:52 PM | Small | View | Financials | 10-K | SEC | Y 2011 ending: 12/31/2011 | Rev: $81,166,739 +9.1% | Assets $156,390,991 | EPS $0.44 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 3/6/2012 5:23:08 PM | Small | View | Financials | 10-Q/A | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $20,987,725 +12.4% | Assets $150,943,437 | EPS $0.11 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/14/2011 9:10:17 AM | View | Proxy | SEC | Y 2010 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/10/2011 4:28:25 PM | Small | View | Financials | 10-Q | SEC | 3Q 2011 ending: 9/30/2011 | Rev: $20,987,725 +12.4% | Assets $150,943,437 | EPS $0.11 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 9/6/2011 4:51:19 PM | Micro | View | Financials | 10-Q/A | SEC | 2Q 2011 ending: 6/30/2011 | Rev: $19,600,852 +17.9% | Assets $143,439,197 | EPS $0.12 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 11/12/2010 5:16:09 PM | View | Proxy | SEC | Y 2009 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 5/5/2010 4:28:43 PM | View | Proxy | SEC | Y 2009 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 9/23/2009 10:58:01 AM | View | Proxy | SEC | Y 2008 | ||||||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | 6/25/2009 10:32:21 AM | View | Proxy | SEC | Y 2008 |